Mrs. Patti Lynn Hass, CNS Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-2063 |
Jorge Torres, CNS Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: Brooke Army Medical C Enter, Fort Sam Houston, TX 78234 Phone: 210-916-0828 |
Ms. Sarah Shingleton, MS, RN, CCRN, CCNS Clinical Nurse Specialist - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Mche-qd (creds), Fort Sam Houston, TX 78234 Phone: 210-916-0651 |
Ms. Nancy Addie Khan, RN, MSN, CNS, APN-BC Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234 Phone: 210-916-4193 Fax: 210-916-3051 |
Dr. Kathryn M. Gaylord, PMH-CNS Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 3400 Rowley E. Chambers Avenue, United States Army Institute Of Surgical Research, Fort Sam Houston, TX 78234 Phone: 210-916-3527 |
Mrs. Mary Scott Mcnabb, RN, CS, MSN Clinical Nurse Specialist - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Mche-qd (credentials), Fort Sam Houston, TX 78234 Phone: 210-916-0626 Fax: 210-916-8866 |
Ms. Deborah Bray, R, MSN, CNS Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Brooke Army Medical Center Mche-qd/credentials, Fort Sam Houston, TX 78234 Phone: 210-916-0945 Fax: 210-916-0709 |
Ms. Mary Lee Jones, CNS Clinical Nurse Specialist - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr, Fort Sam Houston, TX 78234 Phone: 210-916-8678 |
Mr. Allan Boudreaux, MSN, RN, CCNS, CEN Clinical Nurse Specialist - Emergency Medicare: Not Enrolled in Medicare Practice Location: 3851 Roger Brooke Dr., Mche-qd (creds), Brooke Army Medical Center, Fort Sam Houston, TX 78234 Phone: 210-916-3390 |
News Archive
Idera Pharmaceuticals, Inc. today presented data from a preclinical study evaluating the mechanism of action of a Toll-like Receptor (TLR) antagonist in a preclinical model of atherosclerosis. The presentation entitled "A novel antagonist of TLR7 and TLR9 exerts anti atherogenic effects in ApoE-/- mouse model of atherosclerosis" (abstract P259) was made by Idera scientists at the American Heart Association conference "Arteriosclerosis, Thrombosis and Vascular Biology 2010 Scientific Sessions" being held April 8-10 in San Francisco, CA.
Working with mice, scientists at Johns Hopkins have successfully used a commonly prescribed blood pressure medicine, losartan (Cozaar), to prevent almost all of the lung damage caused from two months of exposure to cigarette smoke. The treatment specifically targeted lung tissue breakdown, airway wall thickening, inflammation and lung over-expansion.
Noting the successes of the first 10 years of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as well as the funding challenges it faces moving forward, Elisha Dunn-Georgiou, vice president of advocacy at Population Action International, writes in an opinion piece in GlobalPost's "Global Pulse" blog that the Fund "has always upheld the idea that their work contributes to achievement of all of the health-related Millennium Development Goals (MDGs)" and "always accepted and considered proposals that include reproductive, maternal, and child health interventions, when countries could demonstrate that they would have an impact on AIDS, tuberculosis, and malaria."
Dr. Olivier Collignon of the University of Montreal's Saint-Justine Hospital Research Centre compared the brain activity of people who can see and people who were born blind, and discovered that the part of the brain that normally works with our eyes to process vision and space perception can actually rewire itself to process sound information instead.
Three lethal human respiratory syndromes associated with coronavirus (CoV) infections have emerged in the past two decades. They are severe acute respiratory syndrome (SARS) in 2002, Middle East respiratory syndrome (MERS) in 2012, and coronavirus disease 2019 (COVID-19) in 2019.
› Verified 3 days ago